3-D QSAR Investigations of the Inhibition ofLeishmaniamajorFarnesyl Pyrophosphate Synthase by Bisphosphonates
- 21 October 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (24) , 5171-5183
- https://doi.org/10.1021/jm0302344
Abstract
We report the activities of 62 bisphosphonates as inhibitors of the Leishmania major mevalonate/isoprene biosynthesis pathway enzyme, farnesyl pyrophosphate synthase. The compounds investigated exhibit activities (IC50 values) ranging from ∼100 nM to ∼80 μM (corresponding to Ki values as low as 10 nM). The most active compounds were found to be zoledronate (whose single-crystal X-ray structure is reported), pyridinyl-ethane-1-hydroxy-1,1-bisphosphonates or picolyl aminomethylene bisphosphonates. However, N-alicyclic aminomethylene bisphosphonates, such as incadronate (N-cycloheptyl aminomethylene bisphosphonate), as well as aliphatic aminomethylene bisphosphonates containing short (n = 4, 5) alkyl chains, were also active, with IC50 values in the 200−1700 nM range (corresponding to Ki values of ∼20−170 nM). Bisphosphonates containing longer or multiple (N,N-) alkyl substitutions were inactive, as were aromatic species lacking an o- or m-nitrogen atom in the ring, or possessing multiple halogen substitutions or a p-amino group. To put these observations on a more quantitative structural basis, we used three-dimensional quantitative structure−activity relationship techniques: comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA), to investigate which structural features correlated with high activity. Training set results (N = 62 compounds) yielded good correlations with each technique (R2 = 0.87 and 0.88, respectively), and were further validated by using a training/test set approach. Test set results (N = 24 compounds) indicated that IC50 values could be predicted within factors of 2.9 and 2.7 for the CoMFA and CoMSIA methods, respectively. The CoMSIA fields indicated that a positive charge in the bisphosphonate side chain and a hydrophobic feature contributed significantly to activity. Overall, these results are of general interest since they represent the first detailed quantitative structure−activity relationship study of the inhibition of an expressed farnesyl pyrophosphate synthase enzyme by bisphosphonate inhibitors and that the activity of these inhibitors can be predicted within about a factor of 3 by using 3D-QSAR techniques.This publication has 27 references indexed in Scilit:
- A Quantitative Structure−Activity Relationship and Pharmacophore Modeling Investigation of Aryl-X and Heterocyclic Bisphosphonates as Bone Resorption AgentsJournal of Medicinal Chemistry, 2003
- Farnesyl Pyrophosphate Synthase Is an Essential Enzyme in Trypanosoma bruceiJournal of Biological Chemistry, 2003
- Activity of Bisphosphonates againstTrypanosoma bruceirhodesienseJournal of Medicinal Chemistry, 2002
- Bisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate SynthasePublished by Elsevier ,2001
- HIV andLeishmaniaCoinfection: A Review of 91 Cases with Focus on Atypical Locations ofLeishmaniaClinical Infectious Diseases, 2000
- Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid PathwayBiochemical and Biophysical Research Communications, 1999
- Nitrogen-Containing Bisphosphonates as Carbocation Transition State Analogs for Isoprenoid BiosynthesisBiochemical and Biophysical Research Communications, 1999
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological ActivityJournal of Medicinal Chemistry, 1994
- Atomic charges derived from semiempirical methodsJournal of Computational Chemistry, 1990